A possible protective role for Bacillus Calmette-Guérin therapy in urinary bladder cancer in the era of COVID-19: a brief report

Given the systemic immunogenic effects of Bacillus Calmette-Guérin (BCG) therapy in patients with bladder cancer and its non-specific immunogenic effects in viral respiratory diseases, we aimed to study severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in bladder cancer patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohadian Moghadam, Solmaz, Abbasi, Behzad, Nowroozi, Ali, Amini, Erfan, Nowroozi, Mohammad Reza, Momeni, Seyed Ali, Niroomand, Hassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Vaccine Society 2021
Materias:
COVID-19 Special
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217577/
https://www.ncbi.nlm.nih.gov/pubmed/34222132
http://dx.doi.org/10.7774/cevr.2021.10.2.191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217577/
https://www.ncbi.nlm.nih.gov/pubmed/34222132
http://dx.doi.org/10.7774/cevr.2021.10.2.191

Ejemplares similares